ArticleReproduction & fertility2026
Combined nonoxynol-9 and antimicrobial peptide LL-37 for barrier contraception.
Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Birth control and sexually transmitted infections are global concerns. Nonoxynol-9 (N-9) is the most commonly used component in spermicides, with controversial safety and efficacy. LL-37 has been considered the most promising antimicrobial peptide for developing spermicides. Thus, we aimed to refine the regime of N-9 through the adjunction of LL-37 with higher spermicidal efficacy, safety, and antimicrobial activity. Processed sperm from density gradient centrifugation were treated with nonoxynol-9, LL-37, or the combination for the spermicidal activity. Acrosome reaction, DNA fragmentation, and hemizona binding were evaluated. Minimal inhibitory concentrations were measured using E. coli. Mouse experiments were conducted to investigate skin and vagina irritations. The spermicidal activities of nonoxynol-9 and LL-37 were dose-dependent. Premature acrosome reactions were shown in both groups by increasing acrosome-reacted sperm at around 9 and 21% significantly, and interestingly, the combined group showed a synergistic effect by raising over 60%. In the DNA fragmentation, although there were no significant changes in the nonoxynol-9 or LL-37 groups, the combined group showed a 3% increase at a significant level. Both nonoxynol-9 and LL-37 showed reduced binding capacity with the hemizona-binding indexes at 43.2 and 8.0, and the combined group showed the lowest capacity at 5.6. In animal experiments, the addition of LL-37 to the nonoxynol-9 could alleviate the disruptions caused by nonoxynol-9 in reducing skin epidermal hyperplasia and vaginal irritation. However, the presence of nonoxynol-9 would reduce the antibacterial activity of LL-37. This refined regime showed enhanced spermicidal effects and reduced irritations, but only limited antimicrobial activity. Lay summary: Birth control and sexually transmitted infections are global concerns. One of the most common components used in spermicides to kill sperm is nonoxynol-9, but there have been questions about safety and efficacy. LL-37 has been considered a promising component, together with its function in killing microbes. We aimed to design a spermicide using N-9 and LL-37 together, with potentially higher efficacy and safety. This refined regime showed improvements in killing sperm and improved effects on sperm functions. It also reduced the irritation to the skin and vagina, but only showed limited activity in killing the microbes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.